Evidence obtained in human and mice have revealed that IL-33 is released early after viral challenge (within 2 days of infection), and predominantly in areas of acute lung inflammation where it drives immune cellular influx and de novo il-33 gene expression in lung cells [35]. This evidence concerns the gene IL33 and infection.